Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
Deray
Gilbert
G
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000453:epidemiology; D003287:Contrast Media / Q000009:adverse effects; D017023:Coronary Angiography / Q000009:adverse effects / Q000379:methods; D003327:Coronary Disease / Q000150:complications / Q000000981:diagnostic imaging*; D006801:Humans; D015994:Incidence; D007485:Ioxaglic Acid / Q000009:adverse effects*; D011379:Prognosis; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D018570:Risk Assessment; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
D003287:Contrast Media; D014283:Triiodobenzoic Acids; C044834:iodixanol; D007485:Ioxaglic Acid